About

Armstrong helps guide IU’s efforts to further economic development and job creation, to support new business ventures, to transfer IU-developed technologies to the marketplace, and to build partnerships with businesses and universities across Indiana and throughout the nation and the world. In this role, he established the Innovate Indiana Fund and the Indiana Philanthropic Venture Fund.

Prior to this appointment, Armstrong served as Executive Director of the IU Office of Engagement and as Associate Director of the Office of Technology Commercialization at IU’s Advanced Research and Technology Institute. He also served as the Executive Director and General Counsel of the Indiana 21st Century Research and Technology Fund. In that role, he managed a $140 million fund that provided early-stage investments for collaborative research partnerships and cultivated high-tech industries for the state of Indiana.

A native of Madison, Indiana, Tony holds a B.S. from the IU Kelley School of Business, a J.D. from the IU School of Law – Bloomington, and an M.B.A. from Butler University.

Teri returned to Indiana in 2018 to join Indiana University as an Executive Director of IU Ventures and to launch and manage the new Indiana Philanthropic Venture Fund (IU PhV). She is a member of The Dimension Mill/Velocities Investment Committee, a Director of the Venture Club of Indiana, an Advisor to OnCode Institute in the Netherlands, an Advisor to the Frankel Innovation Initiative and serves on the Board of several early stage companies.

Her career has been about starting and re-organizing university technology transfer programs and launching new early stage funds that invest in university science-based ventures.

Teri served as Vice President of Cold Spring Harbor Laboratory leading a new program for industry engagement, new ventures and intellectual property licensing; Vice President for Technology and Business Development for Mount Sinai School of Medicine; founding Chief Executive of Cambridge Enterprise, Ltd the technology commercialization affiliate of the University of Cambridge in England, which included the launch of the Discovery Fund; founder and Managing Partner of ARCH Development Partners, a seed and early stage venture fund focused on university and corporate spin-outs; Business Development for Endocyte, Inc., University of Notre Dame Business School Adjunct Faculty; and Vice President of Start-ups at ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Her prior experience also includes non-executive board positions with several early stage companies, technology transfer leadership roles at Northwestern University and Purdue Research Foundation, including the partnership to launch Cook Biotech, founding membership on the Indiana 21st Century Fund Board and business development for International Minerals and Chemical.

Teri has been an advisor to policy makers, universities, and companies, is a past President of the Association of University Technology Managers (AUTM), a former Bye Fellow of Christ’s College Cambridge in England and a Sagamore of the Wabash.

Jason Whitney serves as Vice President of Venture Development and Executive Director for the Indiana University Angel Network, supporting and developing Indiana University affiliated entrepreneurial ecosystems nationwide.

Whitney’s responsibilities include managing the operations of the IU Angel Network, leveraging new and existing partnerships to fully benefit IU entrepreneurs, and conducting business development and due diligence activities for the IU Philanthropic Venture Fund.

Prior to his appointment, Whitney served as Vice President for Launch Indiana at Launch Fishers where he was responsible for the development and execution of the statewide innovation-driven entrepreneurial capacity building.

Jason holds a B.S. in management from the O’Neill School of Public and Environmental Affairs at Indiana University.

Mike Burton serves as Chief Financial Officer for IU Ventures. His responsibilities include strategic planning, financial management and reporting, budgeting and operations.

Burton holds a B.S. in accounting from Ball State University and is a licensed certified public accountant in both Indiana and Florida. He is a member of the Indiana CPA Society and the American Institute of CPAs.

Starting a new venture is hard and requires more than a great idea. Offering start-up support to IU affiliated founders is essential. Mentorship, access to talent, early-stage funding opportunities, networking, and connections to resources are critical to success. In his role as Vice President – Engagement, Jon is focused on activating and cultivating the global IU Founders and Funders Network.

Barada’s responsibilities include alumni and student engagement, marketing, fundraising, angel network development and a little bit of a lot more. Previously, Barada served as President and CEO of the Bloomington Health Foundation where he oversaw deployment of a $35M fund dedicated to helping the people of Bloomington and neighboring communities lead healthier lives.

Originally from Rushville, Indiana, Jon holds a BS from the Kelley School of Business and an MBA from Butler University. Jon and his wife, Brooke, have three children: Kate (15), Ellie (14), and Ben (12).

James (Jim) Fielding is a veteran Consumer Products, Media, and Retail executive whose positions have included President of Consumer Products and Innovation for Fox Television Group and Twentieth Century Fox Film Corporation, Global Head of Consumer Products and Retail at DreamWorks Animation, and CEO of Claire’s Stores Inc. Over his career, Fielding has held key roles in the merchandising world at companies from Lands’ End, Inc. and The Gap to The J. Peterman Company and Dayton Hudson Department Store. Jim also served as President of Disney Stores Worldwide during his 12 year tenure with the firm. Jim is currently a Partner in
Archer Gray, an independent Media company best known for Film and Broadway productions, specializing in talent from historically underrepresented voices.

He also currently serves as Executive in Residence working with the IU Ventures Team and the Office of the Vice-President for Diversity, Equity, and Multicultural Affairs. In this role, Jim lends his expertise to special projects like Strategic Planning, Branding and Marketing priorities, and working on Student Engagement.

Fielding earned a B.A. in Political Science and Management from Indiana University. Jim currently serves on the IU Foundation Board of Directors. He is a founding member of the Queer Philanthropy Circle, and a proud member of the Black Philanthropy Circle and Women’s Philanthropic Leadership Council. He served on the Hamilton Lugar School Dean’s Advisory Council from 2016-2019, contributing his energy, enthusiasm, and marketing expertise as well as giving generously to establish the James D. Fielding Family Study Abroad Scholarship and the James D. Fielding Internship Abroad Scholarship. Jim has also funded a Leadership and Advocacy Scholarship Fund through OVPDEMA. Fielding is an active Angel and Seed investor, and mentors many Start-Up founders and teams.

Emily Atkinson has a BS in Health and Rehabilitation Science and recently graduated with a PhD in Anatomy, Cell Biology, and Physiology from IU School of Medicine. During her PhD studies she investigated multiple cross-functional disease areas including musculoskeletal health, metabolism, and oncology.

She is well versed in scientific writing and was an NIH-funded pre-doctoral investigator for her thesis work. Throughout her graduate career, Emily developed a passion for scientific outreach and bridging the gap between science and society. She is eager to expand her scientific and communication expertise with an introduction to biotech focused venture capital and portfolio management.

She believes venture capital will not only utilize, but synthesize her knowledge in cell biology and scientific communication to holistically push science forward and efficiently bring innovations from the bench to the public. Outside of work, Emily enjoys traveling to and hiking the National Parks, taking care of her two dogs, and supporting local coffee shops.

Kate Evinger serves as Senior Venture Analyst with IU Ventures. Kate holds a B.S. in Finance with a Co-Major in Entrepreneurship and Corporate Innovation from the Kelley School of Business at Indiana University.

Kate has over 6 years of experience within venture, having previously worked with nationally-ranked startup accelerator, gener8tor, throughout her undergraduate career at IU and into post-grad. In total during her time with gener8tor, Kate worked with 45 startup companies, helped to allocate over $1.4M in venture investments and was a two-time recipient of the Twin Cities “Inno Under 25” for her work in the Twin Cities entrepreneurial ecosystem. Kate also led the development and launch of a scale up program for Seed and Series A sports technology startups with Houston-based sports holding company, Pokatok, where she created programming to share resources and provide introductions to investors, advisors and subject matter experts for participating companies.

Kate looks forward to pairing her passion for entrepreneurship and IU to help support and uplift IU affiliated entrepreneurs.

Quick is the owner of Avalyn Quick Enterprises LLC, which develops plans and processes to help individuals or organizations achieve goals and unlock potential. She brings over 30 years of combined corporate, entrepreneurial and nonprofit board experience to her coaching consultancy practice that serves multiple industries and functional areas. Her experience spans startups to Fortune 500 corporations, where she drove the development and execution of strategies and helped launch an in-house training program focused on entrepreneurial skills,

increasing the scalability of minority-owned businesses and establishing peer-to-peer best practices.

Brady, who describes herself as a serial entrepreneur, has two successful exits of business-to-business companies and over 20 years of experience working as an entrepreneur in digital technologies and digital health. Brady’s expertise includes bringing to market new health care technologies like dementia-focused, AI-driven decision support and behavioral telehealth for those with multiple chronic conditions.

Ezzeddine is a board member for IU Ventures portfolio company NERx Biosciences and CEO of IU spin-out Airbase Breathing Co. In 2010, she helped found X-Chem Pharmaceuticals and was appointed its chief business officer. She was instrumental in crafting the company’s business strategy and in establishing multiple revenue-generating partnerships with top-tier pharmaceutical companies — including AstraZeneca, Bayer, BMS, Johnson & Johnson, Pfizer, Roche and Sanofi — with a cumulative deal value surpassing $2 billion.

Fielding is a veteran executive in consumer products, media and retail whose positions have included president of consumer products and innovation for Fox Television Group and 20th Century Fox Film Corp.; global head of consumer products and retail at DreamWorks Animation; and CEO of Claire’s Stores Inc. Fielding also served as president of Disney Stores Worldwide during his 12-year tenure with the firm. He is currently a partner in Archer Gray, an independent media company best known for film and Broadway productions, specializing in talent from historically underrepresented voices.

Moynihan is chief commercial officer of Genezen Laboratories, a contract development and manufacturing company focused on good manufacturing practice in the cell and gene therapy space. Moynihan’s previous experience includes working as associate vice president of IU Ventures and acting director of the Innovation and Commercialization Office at IU. She served the same role at the University of Michigan’s Office of Technology Transfer.

Ginther is a venture associate at High Alpha, a leading business-to-business software-as-a-service venture studio in Indianapolis. She was previously a senior associate and head of platform for IU Ventures. Ginther began her career in marketing and business development for the behavioral health care industry. She is a board member for the Venture Club of Indiana and a board observer for The Bee Corp.

Wong is chief commercial officer of Geneoscopy, a venture-backed developer of gastrointestinal diagnostics. Wong forged a successful 17-year career at Roche Diagnostics, where he held senior leadership roles in strategy, business development, marketing, communications, market access and sales. At Roche, he was general manager of a $600 million business unit, leading 350 employees serving a broad range of customer segments, from BioPharma firms to individual patients.

Kathy is a general partner at JMI Equity, a growth equity firm focused on investing in leading software companies. Kathy was brought in to lead deal structuring and execution and SEC registration, and until November 2021 was also CCO and GC responsible for compliance, legal, and firm administrative functions. Kathy sits on the boards of Swiftly, Kognitiv, the American Online Giving Foundation, Inc., and Friends of Downtown San Diego. She sat on the board of SpaceIQ until its combination with iOffice in 2021.

Prior to joining JMI, Kathy was a partner in the corporate, private equity and technology companies groups at Goodwin Procter LLP, where she was a founding partner and co-chair of the Silicon Valley office.

Mark’s 20+ years of experience spans medical device (Biomet, Zimmer, Tornier), pharma / biotech (Roche), and life-science (Vanderbilt Tech Transfer) including corporate, early stage, and start-up environments. Mark has led multiple new product development and commercialization efforts across the globe, including surgical robotics / software, surgical implants, and biologic technologies among others. From 2015-2021, Mark was co-founder, CEO, and board member for Owl Manor Medical, LLC, an animal health biologics / medical device company. Owl Manor established a successful US and international business (Europe, Middle East, Canada and Mexico) whose portfolio was acquired by Zoetis, Inc. in June 2021. Mark’s forte is evaluating, initiating, managing, and growing new business ventures / opportunities from inception through exit.